![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 17, 15421-15428, April 25, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and
From the Department of Pharmacology and Cell Biophysics,
College of Medicine, University of Cincinnati,
Cincinnati, Ohio 45267-0575
Vascular endothelial growth factor
(VEGF) stimulates angiogenesis during development and in disease.
In pheochromocytoma (PC12) cells, VEGF expression is regulated by
A2A adenosine receptor (A2AAR)
activation. The present work examines the underlying signaling pathway.
The adenylyl cyclase-protein kinase A cascade has no role in the
down-regulation of VEGF mRNA induced by the A2AAR agonist,
2-[4-[(2-carboxyethyl)phenyl]ethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680). Conversely, 6-h exposure of cells to either phorbol 12-myristate 13-acetate (PMA) or protein kinase C (PKC) inhibitors mimicked the CGS21680-induced down-regulation. PMA activated PKC
, PKC
, and PKC
, and CGS21680 activated PKC
and PKC
as
assessed by cellular translocation. By 6 h, PMA but not CGS21680
decreased PKC
and PKC
expression. Neither compound affected
PKC
levels. Following prolonged PMA treatment to down-regulate
susceptible PKC isoforms, CGS21680 but not PMA inhibited the cobalt
chloride induction of VEGF mRNA. The proteasome inhibitor, MG-132,
abolished PMA- but not CGS21680-induced down-regulation of VEGF mRNA.
Phorbol 12,13-diacetate reduced VEGF mRNA levels while
down-regulating PKC
but not PKC
expression. In cells
expressing a dominant negative PKC
construct, CGS21680 was
unable to reduce VEGF mRNA. Together, the findings suggest that phorbol
ester-induced down-regulation of VEGF mRNA occurs as a result of
a reduction of PKC
activity, whereas that mediated by the
A2AAR occurs following deactivation of PKC
.
Supported by National Institutes of Health Training Grant 5T32 HL07382.
§
To whom correspondence should be addressed. Tel.:
513-558-2361; Fax: 513-558-1169; E-mail: mark.olah@uc.edu.
This article has been cited by other articles:
![]() |
Y. Sun, F. Wu, F. Sun, and P. Huang Adenosine Promotes IL-6 Release in Airway Epithelia J. Immunol., March 15, 2008; 180(6): 4173 - 4181. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ikegami, L. Krilov, J. Meng, B. Patel, K. Chapin-Kennedy, and B. Bouscarel Decreased Glucagon Responsiveness by Bile Acids: A Role for Protein Kinase C{alpha} and Glucagon Receptor Phosphorylation Endocrinology, November 1, 2006; 147(11): 5294 - 5302. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pages and J. Pouyssegur Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors Cardiovasc Res, February 15, 2005; 65(3): 564 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Olah and C. C. Caldwell Adenosine Receptors and Mammalian Toll-Like Receptors: Synergism in Macrophages Mol. Interv., October 1, 2003; 3(7): 370 - 374. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |